Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

Beevers, D. et al. (2005) Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A. Lancet, 366(9489), pp. 895-906.

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:McInnes, Professor Gordon
Authors: Beevers, D., Caulfield, M., Collins, R., Dahlof, B., Kjeldsen, S., Kristinsson, A., McInnes, G., Mehlsen, J., Nieminen, M., O'Brien, E., Ostergren, J., Poulter, N., Sever, P., and Wedel, H.
College/School:College of Medical Veterinary and Life Sciences
Journal Name:Lancet

University Staff: Request a correction | Enlighten Editors: Update this record